Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carmen Lerner
Observed name:
C Lerner
Institution:
Boehringer Ingelheim (Germany)
Observed institution:
Boehringer Ingelheim (Germany)
OpenAlex ID:
A5073085181
IL36 is a critical upstream amplifier of neutrophilic lung inflammation in mice
2021
·
Carolin K. Koss
, Christian T. Wohnhaas
, et al.
·
Communications Biology
·
47
PDF
Antifibrotic Drug Nintedanib Inhibits CSF1R to Promote IL-4–associated Tissue Repair Macrophages
2022
·
Carolin K. Watson
, Daniela Schloesser
, et al.
·
American Journal of Respiratory Cell and Molecular Biology
·
35
LSC - 2021 - The Anti-Fibrotic Drug Nintedanib Promotes Repair Macrophages
2021
·
Koss Carolin
, Katrin Fundel-Clemens
, et al.
·
European Respiratory Journal
·
1
Late Breaking Abstract - Discovery of an MMP7‑driven CTGF proteolytic switch as a new therapeutic intervention in IPF
2026
·
Maria Myzithras
, Fidel Ramirez
, et al.
·
European Respiratory Journal
B77-10 Disrupting the CTGF-MMP7 Axis in Pulmonary Fibrosis: A Novel High-affinity Antibody Outperforms Pamrevlumab in Patient-derived Models
2026
·
M Lizé
, M Myzithras
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Disrupting the CTGF–MMP7 Axis in Pulmonary Fibrosis: A Novel High-Affinity Antibody Outperforms Pamrevlumab in Patient-Derived Models
2026
·
Maria Myzithras
, Fidel Ramirez
, et al.
Patient-derived alveolar organoids for drug discovery: Dysregulated epithelial repair in pulmonary fibrosis
2025
·
Heiko Olbrich
, Irina Shalashova
, et al.
·
European Respiratory Journal
Alveolar budding organoids as a novel drug discovery platform for dysregulated epithelial repair in pulmonary fibrosis
2025
·
Heiko Olbrich
, Irina Shalashova
, et al.
The Anti-Fibrotic Drug Nintedanib Promotes Repair Macrophages
2021
·
C Koss
, K Fundel-Clemens
, et al.
·
12.01 - Idiopathic interstitial pneumonias
Show more works
View as search
Works count:
9
Citation count:
83
H-index:
2
I10-index:
2
Year
Topic
Type